Literature DB >> 17909182

Kaposi's sarcoma herpesvirus-encoded latency-associated nuclear antigen stabilizes intracellular activated Notch by targeting the Sel10 protein.

Ke Lan1, Subhash C Verma, Masanao Murakami, Bharat Bajaj, Rajeev Kaul, Erle S Robertson.   

Abstract

Deregulation of the evolutionarily conserved Notch signaling is highly correlated with oncogenesis. Intracellular activated Notch (ICN) is a protooncogene linked to the transcription activation of a number of cellular genes involved in cell cycle regulation, differentiation, and proliferation. Stability of ICN is tightly regulated by the Sel10-mediated ubiquitin-proteasome pathway. Sel10 can function as a negative regulator of Notch and exhibits activities of a tumor-suppressor protein. This article shows that the Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen (LANA) directly interacts with Sel10 and forms a complex in KSHV-infected cells. This results in suppression of ICN ubiquitination and degradation. The carboxyl terminus of LANA interacts with the F-box and WD40 domains of Sel10 and competes with ICN for binding to Sel10. This elevated level of ICN is also critical for maintaining the enhanced proliferation of KSHV-infected tumor cells. These findings describe a mechanism by which the KSHV-encoded LANA protein regulates ubiquitination of ICN mediated by the F-box component of the E3 ligase Sel10, leading to proliferation of the virus-infected cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17909182      PMCID: PMC1997218          DOI: 10.1073/pnas.0703508104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak.

Authors:  E H Cheng; J Nicholas; D S Bellows; G S Hayward; H G Guo; M S Reitz; J M Hardwick
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

2.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

3.  Frequent provirus insertional mutagenesis of Notch1 in thymomas of MMTVD/myc transgenic mice suggests a collaboration of c-myc and Notch1 for oncogenesis.

Authors:  L Girard; Z Hanna; N Beaulieu; C D Hoemann; C Simard; C A Kozak; P Jolicoeur
Journal:  Genes Dev       Date:  1996-08-01       Impact factor: 11.361

Review 4.  Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.

Authors:  Lyubomir A Dourmishev; Assen L Dourmishev; Diana Palmeri; Robert A Schwartz; David M Lukac
Journal:  Microbiol Mol Biol Rev       Date:  2003-06       Impact factor: 11.056

5.  Oncogenic forms of NOTCH1 lacking either the primary binding site for RBP-Jkappa or nuclear localization sequences retain the ability to associate with RBP-Jkappa and activate transcription.

Authors:  J C Aster; E S Robertson; R P Hasserjian; J R Turner; E Kieff; J Sklar
Journal:  J Biol Chem       Date:  1997-04-25       Impact factor: 5.157

6.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

7.  Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands.

Authors:  C Jhappan; D Gallahan; C Stahle; E Chu; G H Smith; G Merlino; R Callahan
Journal:  Genes Dev       Date:  1992-03       Impact factor: 11.361

8.  Inactivation of hCDC4 can cause chromosomal instability.

Authors:  Harith Rajagopalan; Prasad V Jallepalli; Carlo Rago; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Christoph Lengauer
Journal:  Nature       Date:  2004-03-04       Impact factor: 49.962

9.  Regulation and autoregulation of the promoter for the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.

Authors:  Joseph H Jeong; Joshua Orvis; Jong Wook Kim; Curtis P McMurtrey; Rolf Renne; Dirk P Dittmer
Journal:  J Biol Chem       Date:  2004-01-24       Impact factor: 5.157

10.  The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta.

Authors:  Masahiro Fujimuro; S Diane Hayward
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

View more
  30 in total

Review 1.  The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency.

Authors:  Mary E Ballestas; Kenneth M Kaye
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

2.  Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4/K10) is a novel interaction partner of CSL/CBF1, the major downstream effector of Notch signaling.

Authors:  Katharina Heinzelmann; Barbara A Scholz; Agnes Nowak; Even Fossum; Elisabeth Kremmer; Juergen Haas; Ronald Frank; Bettina Kempkes
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

Review 3.  Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.

Authors:  Qiliang Cai; Suhbash C Verma; Jie Lu; Erle S Robertson
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

4.  Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen reduces interleukin-8 expression in endothelial cells and impairs neutrophil chemotaxis by degrading nuclear p65.

Authors:  Xiaofan Li; Deguang Liang; Xianzhi Lin; Erle S Robertson; Ke Lan
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

5.  A herpesvirus transactivator and cellular POU proteins extensively regulate DNA binding of the host Notch signaling protein RBP-Jκ to the virus genome.

Authors:  Olga Gonzalez-Lopez; Jennifer DeCotiis; Corey Goyeneche; Helena Mello; Bryan Alexis Vicente-Ortiz; Hye Jin Shin; Kyla E Driscoll; Peicheng Du; Diana Palmeri; David M Lukac
Journal:  J Biol Chem       Date:  2019-07-15       Impact factor: 5.157

Review 6.  Molecular mechanisms of viral oncogenesis in humans.

Authors:  Nathan A Krump; Jianxin You
Journal:  Nat Rev Microbiol       Date:  2018-11       Impact factor: 60.633

7.  KSHV-induced notch components render endothelial and mural cell characteristics and cell survival.

Authors:  Ren Liu; Xiuqing Li; Anil Tulpule; Yue Zhou; Jeffrey S Scehnet; Shaobing Zhang; Jong-Soo Lee; Preet M Chaudhary; Jae Jung; Parkash S Gill
Journal:  Blood       Date:  2009-11-24       Impact factor: 22.113

8.  Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor.

Authors:  Ke Lan; Masanao Murakami; Bharat Bajaj; Rajeev Kaul; Zhiheng He; Runliang Gan; Michael Feldman; Erle S Robertson
Journal:  Cancer Biol Ther       Date:  2009-11-07       Impact factor: 4.742

9.  Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation.

Authors:  Jie Lu; Subhash C Verma; Masanao Murakami; Qiliang Cai; Pankaj Kumar; Bingyi Xiao; Erle S Robertson
Journal:  J Virol       Date:  2009-05-13       Impact factor: 5.103

10.  Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin.

Authors:  Jie Lu; Hem C Jha; Subhash C Verma; Zhiguo Sun; Shuvomoy Banerjee; Richard Dzeng; Erle S Robertson
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.